Последние исследования

EudraCT Number: 2004-000053-34

Sponsor Protocol Number: 0473081

Start Date: 2004-07-28

Sponsor Name: Orion Corporation, Orion Pharma, Orionintie,

Full Title: Comparison of continuous combined estrogen-progestin regimen in alleviation of estrogen deficiency symptoms of postmenopausal women. A randomized, double-blind, fixed dose, multicentre phase IIIb ...

Medical condition: Postmenopausal estrogen replacement regimen is the therapy of choice for the alleviation of climacteric symptoms. During the past few years, continuous-combined hormone replacement therapy (HRT) ...

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10027304		LLT

Population Age: Adults

Gender: Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2004-000047-18

Sponsor Protocol Number: C-1808

Start Date: 2004-07-27

Sponsor Name: Biogen Idec Ltd.

Full Title: An open-label, multicenter extension study to evaluate the safety and tolerability of natalizumab in subjects with multiple sclerosis who have completed studies C-1801, C-1802, or C-1803.

Medical condition: Male and female subjects with multiple sclerosis who have completed natalizumab studies C-1801, C-1802, or C-1803

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: View results

EudraCT Number: 2004-001125-20

Sponsor Protocol Number: FIRM-ACT

Start Date: 2004-07-26

Sponsor Name: AZIENDA OSPEDALIERA S. LUIGI GONZAGA

Full Title: First International Randomized trial in Metastatic Adrenocortical Cancer Treatment FIRM-ACT Etoposide, Doxorubicin, Cisplatin and Mitotane vs. Streptozotocin and Mitotane

Medical condition: Chemotherapy in patients with locally advanced or metastatic adrenocortical cancer in adults and children

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10001378		HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000562-13

Sponsor Protocol Number: 3151A1-309-EU

Start Date: 2004-07-26

Sponsor Name: Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development

Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, FLEXIBLE-DOSE STUDY OF DVS-233 SR AND VENLAFAXINE ER IN ADULT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER

Medical condition: Major depressive disorder

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LV (Completed) LT (Completed)

Trial results: View results

EudraCT Number: 2004-001201-10

Sponsor Protocol Number: FEN-PPA-401

Start Date: 2004-07-26

Sponsor Name: JANSSEN-CILAG

Full Title: Comparison of transdermal fentanyl PCA and IV morphine PCA in the management of post-operative pain control.

Medical condition: Treatment of moderate to severe post-operative pain in subjects who have undergone an elective major abdominal or orthopaedic surgical procedure.

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10056350		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-000795-14

Sponsor Protocol Number: 0089

Start Date: 2004-07-26

Sponsor Name: AstraZeneca

Full Title: A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects with Severe Acute Necrotizing Pancreatitis

Medical condition: severe acute necrotisng pancreatitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LV (Completed) LT (Completed)

Trial results: View results

EudraCT Number: 2004-001041-15

Sponsor Protocol Number: N3D/FOR-OCA-06

Start Date: 2004-07-26

Sponsor Name: Neuro3d

Full Title: MULTICENTRE, DOUBLE-BLIND, RISING DOSE PARALLEL GROUP STUDY OF THE EFFICACY AND TOLERABILITY OF OCAPERIDONE VERSUS OLANZAPINE IN SCHIZOPHRENIC PATIENTS

Medical condition: The populations of the study will be: -schizophrenic patients according to DSM IV-TR diagnosis -have to present the first symptoms of the schizophrenia for at least one year -have to present an exa...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: LV (Completed)

Trial results: (No results available)

EudraCT Number: 2004-002280-24

Sponsor Protocol Number: NILG-HES 1-03

Start Date: 2004-07-26

Sponsor Name: AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE)

Full Title: THERAPEUTIC AND BIOLOGICAL EFFECTS OF IMATINIB MESYLATE (STI571) IN PRIMARY HYPERESINOPHILIC SYNDROME (HES), CHRONIC EOSINOPHILIC LEUKEMIA (CEL) AND CHRONIC IDIOPHATIC HYPEREOSINOPHILIA (CIH): A ST...

Medical condition: HYPEREOSINOPHILIC SYNDROME (HES, CEL, CIH)

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10024324		HLGT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000337-12

Sponsor Protocol Number: 24810

Start Date: 2004-07-23

Sponsor Name: Serono International SA

Full Title: A multicentre, single arm, open-label, phase IV study to evaluate the immunogenicity and safety of subcutaneously administered r-hIFN beta-1a (Rebif) using clone 484-39 in the treatment of subjects...

Medical condition: MS with 2 or more relapses within the last 2 years

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10028245		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: View results

EudraCT Number: 2004-000362-12

Sponsor Protocol Number: K-832-2.01EU

Start Date: 2004-07-23

Sponsor Name: Kowa Research Europe Ltd

Full Title: A Double-Blind, Randomised, Dose-Ranging Study to Compare K-832 with Placebo in the treatment of Patients with Active Rheumatoid Arthritis

Medical condition: Rheumatoid Arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.0		10028395		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

Последние исследования

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства